Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAG
4626
DELISTED
MAG Silver
MAG
| $402K | ﹤0.01% |
36,077
-187,954
| -84% | -$2.34M |
|
|
CIZN
4627
DELISTED
Citizens Holding Co.
CIZN
| $401K | ﹤0.01% |
32,906
-1,963
| -6% | -$24.5K |
|
4628
PUT
Illinois Tool Works
ITW
$82.6B
| $400K | ﹤0.01% |
1,600
-34,200
| -96% | -$8.01M |
|
4629
Phathom Pharmaceuticals
PHAT
$708M
| $400K | ﹤0.01% |
27,941
-29,922
| -52% | -$345K |
|
4630
Glacier Bancorp
GBCI
$6.42B
| $400K | ﹤0.01% |
+12,818
| New | +$423K |
|
4631
CALL
Biomea Fusion
BMEA
$84.6M
| $399K | ﹤0.01% |
+18,200
| New | +$570K |
|
4632
PUT
United Natural Foods
UNFI
$3.08B
| $399K | ﹤0.01% |
20,400
-5,200
| -20% | -$131K |
|
4633
First Hawaiian
FHB
$3.38B
| $399K | ﹤0.01% |
22,144
-159,904
| -88% | -$2.94M |
|
4634
Atossa Therapeutics
ATOS
$20.6M
| $399K | ﹤0.01% |
21,094
-9,835
| -32% | -$119K |
|
4635
PUT
Capri Holdings
CPRI
$1.83B
| $398K | ﹤0.01% |
+11,100
| New | +$440K |
|
4636
CALL
Sherwin-Williams
SHW
$82.7B
| $398K | ﹤0.01% |
+1,500
| New | +$353K |
|
|
NAAS
4637
NaaS Technology Inc
NAAS
$55.1M
| $398K | ﹤0.01% |
233
+140
| +151% | +$343K |
|
|
TBIO
4638
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $398K | ﹤0.01% |
13,982
-5,132
| -27% | -$205K |
|
4639
Eldorado Gold
EGO
$7.87B
| $397K | ﹤0.01% |
39,316
-797,042
| -95% | -$8.44M |
|
4640
Bank of Marin Bancorp
BMRC
$472M
| $397K | ﹤0.01% |
22,471
-107,958
| -83% | -$1.96M |
|
|
ORAN
4641
DELISTED
Orange
ORAN
| $396K | ﹤0.01% |
+34,017
| New | +$413K |
|
|
DEA
4642
Easterly Government Properties
DEA
$1.13B
| $395K | ﹤0.01% |
10,908
-20,434
| -65% | -$718K |
|
4643
Veritone
VERI
$101M
| $395K | ﹤0.01% |
100,862
-333,193
| -77% | -$1.45M |
|
4644
Simmons First National
SFNC
$3.41B
| $395K | ﹤0.01% |
22,912
-42,053
| -65% | -$708K |
|
4645
Resources Connection
RGP
$151M
| $393K | ﹤0.01% |
25,017
-54,242
| -68% | -$843K |
|
4646
Nomura Holdings
NMR
$28.3B
| $393K | ﹤0.01% |
102,551
+14,666
| +17% | +$54.3K |
|
4647
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.52B
| $392K | ﹤0.01% |
2,667
+1,130
| +74% | +$150K |
|
4648
CALL
InMode
INMD
$870M
| $392K | ﹤0.01% |
+10,500
| New | +$367K |
|
|
GRTX
4649
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $392K | ﹤0.01% |
+125,640
| New | +$374K |
|
4650
CALL
Affirm
AFRM
$23.9B
| $389K | ﹤0.01% |
25,400
+6,700
| +36% | +$88.9K |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.